FDA CDER’s Accelerating Rare disease Cures (ARC) Program
In 2022, the FDA’s Center for Drug Evaluation and Research (CDER) launched the Accelerating Rare...
Posts about
CMC
Navigating Regulatory Challenges in Biologics: A Case Study in Overcoming Clinical Holds
In the intricate world of pharmaceuticals and biotechnology, every step of drug development is...
FDA Guidance Series on Patient-Focused Drug Development (PFDD) to Enhance Product Development and Regulatory Decision Making
As the industry continues to adopt a patient-centric approach, the use of real-world data is...
Executing Patient-Focused Drug Development (PFDD)
Veristat’s Science Advisory Board met on 14 March 2023 to discuss Executing Patient-Focused Drug...
Unleashing Flexibility in a Rare Disease Gene Therapy Clinical Trial
In the world of biotechnology, where groundbreaking discoveries have the potential to change lives,...
Unlock the Secrets of Effective SD File Preparation for FDA Submissions
In today's world where digital transformation is reshaping industries, even the pharmaceutical...